197 related articles for article (PubMed ID: 29266509)
1. 5-fluorouracil combined with cisplatin and mitomycin C as an optimized regimen for hyperthermic intraperitoneal chemotherapy in gastric cancer.
Murata S; Yamamoto H; Shimizu T; Naitoh H; Yamaguchi T; Kaida S; Takebayashi K; Miyake T; Tani T; Tani M
J Surg Oncol; 2018 Mar; 117(4):671-677. PubMed ID: 29266509
[TBL] [Abstract][Full Text] [Related]
2. Feasibility and safety of hyperthermic intraperitoneal chemotherapy using 5-fluorouracil combined with cisplatin and mitomycin C in patients undergoing gastrectomy for advanced gastric cancer.
Murata S; Yamamoto H; Naitoh H; Yamaguchi T; Kaida S; Shimizu T; Shiomi H; Naka S; Tani T; Tani M
J Surg Oncol; 2017 Dec; 116(8):1159-1165. PubMed ID: 28743181
[TBL] [Abstract][Full Text] [Related]
3. Hyperthermic intraperitoneal chemotherapy using a combination of mitomycin C,5-fluorouracil, and oxaliplatin in patients at high risk of colorectal peritoneal metastasis: A Phase I clinical study.
Shimizu T; Sonoda H; Murata S; Takebayashi K; Ohta H; Miyake T; Mekata E; Shiomi H; Naka S; Tani T
Eur J Surg Oncol; 2014 May; 40(5):521-528. PubMed ID: 24388411
[TBL] [Abstract][Full Text] [Related]
4. The Temperature-Dependent Effectiveness of Platinum-Based Drugs Mitomycin-C and 5-FU during Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Colorectal Cancer Cell Lines.
Helderman RFCPA; Löke DR; Verhoeff J; Rodermond HM; van Bochove GGW; Boon M; van Kesteren S; Garcia Vallejo JJ; Kok HP; Tanis PJ; Franken NAP; Crezee J; Oei AL
Cells; 2020 Jul; 9(8):. PubMed ID: 32722384
[TBL] [Abstract][Full Text] [Related]
5. Gene expression changes induced by HIPEC in a murine model of gastric cancer.
Graziosi L; Mencarelli A; Renga B; Santorelli C; Cantarella F; Bugiantella W; Cavazzoni E; Donini A; Fiorucci S
In Vivo; 2012; 26(1):39-45. PubMed ID: 22210714
[TBL] [Abstract][Full Text] [Related]
6. [Large volume intraperitoneal chemotherapy as treatment for the peritoneal carcinomatosis from gastric cancer].
Yamauchi M; Ito A; Kodera Y; Kondo K; Nakahara H; Nagai S; Kuzuya T; Satta T; Ito K; Takagi H
Gan To Kagaku Ryoho; 1992 Apr; 19(4):463-8. PubMed ID: 1558395
[TBL] [Abstract][Full Text] [Related]
7. [Effects of hyperthermic chemotherapy on gastrointestinal cancer cells in vitro].
Sun YM; Fu J; Zhang W; Zheng ZX; Huang CZ; Yuan XH
Ai Zheng; 2006 Aug; 25(8):974-8. PubMed ID: 16965677
[TBL] [Abstract][Full Text] [Related]
8. Peroperative hyperthermic intraperitoneal chemotherapy (HIPEC) for advanced gastric cancer.
de Bree E; Witkamp AJ; Zoetmulder FA
Eur J Surg Oncol; 2000 Sep; 26(6):630-2. PubMed ID: 11034822
[No Abstract] [Full Text] [Related]
9. Mechanism(s) of antitumor action in protracted infusion of low dose 5-fluorouracil and cisplatin in gastric carcinoma.
Kim R; Tanabe K; Inoue H; Toge T
Int J Oncol; 2002 Mar; 20(3):549-55. PubMed ID: 11836567
[TBL] [Abstract][Full Text] [Related]
10. Effect of Hyperthermic Intraperitoneal Perfusion Chemotherapy in Combination with Intravenous Chemotherapy as Postoperative Adjuvant Therapy for Advanced Gastric Cancer.
Wu Z; Ma S; Jing S; Deng Q; Zheng Z; Wu K; Li J; Chen S; Tang R; Li X
Hepatogastroenterology; 2014 Jun; 61(132):972-7. PubMed ID: 26158151
[TBL] [Abstract][Full Text] [Related]
11. [Evaluation of the efficacy and toxicity of protocol cisplatin, 5-fluorouracil, leucovorin compared to protocol fluorouracil, doxorubicin and mitomycin C in locally advanced and metastatic gastric cancer].
Andrić Z; Randjelović T; Kovčin V; Gutović J; Crevar S; Murtezani Z; Kostić S
Srp Arh Celok Lek; 2012; 140(5-6):305-12. PubMed ID: 22826983
[TBL] [Abstract][Full Text] [Related]
12. Heated intraoperative intraperitoneal mitomycin C and early postoperative intraperitoneal 5-fluorouracil: pharmacokinetic studies.
Jacquet P; Averbach A; Stephens AD; Stuart OA; Chang D; Sugarbaker PH
Oncology; 1998; 55(2):130-8. PubMed ID: 9499187
[TBL] [Abstract][Full Text] [Related]
13. Mitomycin C with continuous fluorouracil or with cisplatin in combination with radiotherapy for locally advanced anal cancer (European Organisation for Research and Treatment of Cancer phase II study 22011-40014).
Matzinger O; Roelofsen F; Mineur L; Koswig S; Van Der Steen-Banasik EM; Van Houtte P; Haustermans K; Radosevic-Jelic L; Mueller RP; Maingon P; Collette L; Bosset JF;
Eur J Cancer; 2009 Nov; 45(16):2782-91. PubMed ID: 19643599
[TBL] [Abstract][Full Text] [Related]
14. [Continuous hyperthermic peritoneal perfusion (CHPP) therapy in advanced gastric cancer].
Suzuki H; Miyagishima K; Gasa F; Hakamada K; Seino K; Hada R; Mikami Y; Sugiyama Y; Konn M; Ono K
Gan To Kagaku Ryoho; 1991 Aug; 18(11):1769-72. PubMed ID: 1908652
[TBL] [Abstract][Full Text] [Related]
15. Clinical study of cisplatin hyperthermic intraperitoneal perfusion chemotherapy in combination with docetaxel, 5-flourouracil and leucovorin intravenous chemotherapy for the treatment of advanced-stage gastric carcinoma.
Zhibing W; Qinghua D; Shenglin M; Ke Z; Kan W; Xiadong L; Pengjun Z; Ruzhen Z
Hepatogastroenterology; 2013; 60(125):989-94. PubMed ID: 23598741
[TBL] [Abstract][Full Text] [Related]
16. [Chemotherapy of scirrhous gastric cancer].
Wakui A
Gan To Kagaku Ryoho; 1994 Oct; 21(14):2398-406. PubMed ID: 7944483
[TBL] [Abstract][Full Text] [Related]
17. In-vitro effect of a combination of 5-fluorouracil (5-FU) and cisplatin (CDDP) on human gastric cancer cell lines: timing of cisplatin treatment.
Cho H; Imada T; Oshima T; Shiozawa M; Rino Y; Takanashi Y
Gastric Cancer; 2002; 5(1):43-6. PubMed ID: 12021859
[TBL] [Abstract][Full Text] [Related]
18. The role of additional chemotherapy with oral UFT in intravenous combination chemotherapy with cisplatin and 5-fluorouracil for human gastric cancer xenograft lines of well- and poorly- differentiated adenocarcinomas transplanted in nude mice.
Tseng CC; Nio Y; Tsubono M; Kawabata K; Masai Y; Hayashi H; Fukumoto M; Tobe T
Anticancer Res; 1992; 12(4):1295-9. PubMed ID: 1503424
[TBL] [Abstract][Full Text] [Related]
19. Low-dose all-trans retinoic acid enhances cytotoxicity of cisplatin and 5-fluorouracil on CD44(+) cancer stem cells.
Najafzadeh N; Mazani M; Abbasi A; Farassati F; Amani M
Biomed Pharmacother; 2015 Aug; 74():243-51. PubMed ID: 26349992
[TBL] [Abstract][Full Text] [Related]
20. Low-dose cisplatin-5-fluorouracil prevents postoperative suppression of natural killer cell activity in patients with gastrointestinal cancer.
Ishikawa K; Shimoda K; Shiraishi N; Adachi Y; Kitano S
Jpn J Clin Oncol; 1998 Jun; 28(6):374-7. PubMed ID: 9730152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
